Eugia Pharma Receives USFDA Approval for Cyanocobalamin Injection, 1,000 µg/mL, 1 mL Vials

Eugia Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cyanocobalamin Injection, 1,000 µg/mL, 1 mL Vials.

Indications for this product include:

• Vitamin B12 deficiencies due to malabsorption;
• Cyanocobalamin injection is also suitable for the vitamin B12 absorption test (Schilling test).

Refer to package insert for full prescribing information.